Token Communities, Ltd. Announces Entry into Distribution Agreement
25 juil. 2023 14h04 HE
|
Token Communities Ltd
BRADENTON, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (Symbol: TKCM, “Token Communities” or the “Company”), today announced that the Company’s subsidiary Elements of Health and...
Blood Glucose Monitoring System Market revenue to hit USD 46 Billion by 2033, says Research Nester
13 juil. 2023 07h30 HE
|
Research Nester
New York, July 13, 2023 (GLOBE NEWSWIRE) -- The global blood glucose monitoring system market size is expected to expand at ~10% CAGR from 2023 to 2033. The market is anticipated to garner a revenue...
Token Communities, Ltd. Announces Launch of its First Two Naturopathic Supplements
16 juin 2023 10h16 HE
|
Token Communities Ltd
BRADENTON, Fla., June 16, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (“Token Communities” or the “Company”), today announced that the Company has launched the first two of its naturopathic...
BioAegis Therapeutics Announces Two Studies Exploring the Role of ‘Inflammation Regulator’ Gelsolin in Type 2 Diabetes
13 avr. 2023 14h03 HE
|
BioAegis Therapeutics
Gelsolin decreased microparticle-driven inflammation and mitigated activation of the NLRP3 inflammasome in type 2 diabetes. Low levels of gelsolin identified in individuals with type 2 diabetes...
Artificial Pancreas Device System (APDS) Market Worth $3.58Bn, Globally, by 2028 at 20.28% CAGR | The Insight Partners
05 avr. 2023 05h52 HE
|
The Insight Partners
Pune, INDIA., April 05, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Artificial Pancreas Device System Market Forecast to 2028 – by Type and Geography,” the market is expected to...
French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug
23 janv. 2023 03h10 HE
|
AdipoPharma
Newton Biocapital II Leads Funding Round For First-of-Its-Kind Drug to Treat Insulin ResistanceFirst Breakthrough Addressing Insulin Resistance in Type 2 Diabetes TreatmentSTRASBOURG, France,...
Blood Glucose Monitoring Devices Market to reach $28.76 Billion in 2030 with a CAGR of around 7.92%
02 juin 2022 11h28 HE
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 02, 2022 (GLOBE NEWSWIRE) -- Blood glucose monitoring is the utilization of a glucose meter for monitoring and identifying the overall concentration content of glucose...
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
14 mars 2022 09h15 HE
|
GlucoTrack, Inc.
To begin trading under the Nasdaq Symbol GCTK Rutherford, NJ and Or Yehuda, Israel, March 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), formerly...
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
29 oct. 2021 09h54 HE
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements
12 août 2021 09h15 HE
|
Integrity Applications, Inc.
Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring...